Primary staging of prostate cancer using 68Ga-PSMA PET/CT

被引：0
|
作者：
Graziani, T. [1 ,2 ]
Scarlattei, M. [1 ,2 ]
Baldari, G. [1 ,2 ]
Migliari, S. [1 ,2 ]
Sammartano, A. [1 ,2 ]
Gasparro, D. [2 ,3 ]
Maestroni, U. [2 ,4 ]
Ruffini, L. [1 ,2 ]
机构：
[1] Univ Hosp Parma, Div Nucl Med, Parma, Italy
[2] Univ Hosp Parma, Prostate Canc Unit, Parma, Italy
[3] Univ Hosp Parma, Div Oncol, Parma, Italy
[4] Univ Hosp Parma, Div Urol, Parma, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0475
引用
收藏
页码：S599 / S600
页数：2
相关论文
共 50 条
  • [31] Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
    Pyka, Thomas
    Okamoto, Shozo
    Dahlbender, Marielena
    Tauber, Robert
    Retz, Margitta
    Heck, Matthias
    Tamaki, Nagara
    Schwaiger, Markus
    Maurer, Tobias
    Eiber, Matthias
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2114 - 2121
  • [32] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    CURRENT MEDICAL IMAGING, 2024, 20
  • [33] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [34] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
  • [35] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Christos Sachpekidis
    P. Bäumer
    K. Kopka
    B. A. Hadaschik
    M. Hohenfellner
    A. Kopp-Schneider
    U. Haberkorn
    A. Dimitrakopoulou-Strauss
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 904 - 912
  • [36] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Sachpekidis, Christos
    Baeumer, P.
    Kopka, K.
    Hadaschik, B. A.
    Hohenfellner, M.
    Kopp-Schneider, A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (06) : 904 - 912
  • [37] Diagnostic performance of 68Ga-PSMA PET/CT for restaging prostate cancer
    Hoffmann, Manuela
    Wieler, Helmut
    Maller-Habenthal, Jonas
    Trampert, Ludwin
    Miederer, Matthias
    Schreckenberger, Mathias
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [38] The Role and Impact of 68Ga-PSMA PET/CT in Primary Staging of Prostate Cancer: Preliminary Results in Relation to AJCC Risk Group Staging
    Aktas, L. Ege
    Korkmaz, U.
    Akdere, H.
    Altun, G. Durmus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S19 - S20
  • [39] Impact of 68Ga-PSMA PET for primary radiotherapy management of prostate cancer
    Karahissarlian, V.
    Pommier, P.
    Isnardi, V.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 280 - 283
  • [40] Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
    Martin T. Freitag
    Jan P. Radtke
    Boris A. Hadaschik
    A. Kopp-Schneider
    Matthias Eder
    Klaus Kopka
    Uwe Haberkorn
    Matthias Roethke
    Heinz-Peter Schlemmer
    Ali Afshar-Oromieh
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 70 - 83
12345